About the client

Amgen is a biotechnology company founded in 1980. It develops innovative medicines, advances research, and supports patients around the world through therapies and biomanufacturing expertise.

Challenge

Amgen’s digital presence had become fragmented across brands, product lines, and regions. This made it harder to keep messaging consistent, meet regulatory requirements, and manage content efficiently. The company needed a scalable platform that could support global sites, local market needs, secure patient information, and faster marketing insight.

Solution

XCentium helped Amgen create a unified digital platform for multiple global brands and audiences. The solution used Sitecore 9 to support personalized content, real-time data insights, and a more consistent experience across regions.

XCentium used Helix architecture to support scalability and consistency across five global brands. Brightcove was integrated to deliver video content for healthcare professionals and patients.

The platform was built on Amazon Web Services to support security, reliability, and performance. XCentium also created a branching strategy that supported multiple deployments per month while aligning with the MAC review process. For Aimovig, XCentium designed and launched a secure patient portal that met FDA requirements.

Outcomes

Amgen gained a more unified, scalable, and compliant digital platform. Healthcare professionals and patients could more easily access relevant content, including research, treatment information, educational materials, and support tools.

Marketing teams gained access to real-time analytics to help improve campaigns and content performance. The deployment approach also helped Amgen move content and features through review more efficiently while maintaining compliance.

Technology

• Sitecore 9
• Amazon Web Services
• Brightcove